PTC Therapeutics Inc. and Hopewell Campus Owner, LLC, as successor-in-interest to Bristol-Myers Squibb Company (the ?Landlord?), entered into an amendment and restatement of the lease of office, production and laboratory space at a facility located in Hopewell Township, New Jersey. The amendments to the Lease significantly reduce the space and corresponding rent subject to the Lease. As a result of the amendments to the Lease, the Company no longer considers the Lease to be material.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.53 USD | +0.05% |
|
-0.95% | -19.06% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.06% | 84.19B | |
+55.32% | 815B | |
+43.30% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.04% | 242B | |
+2.21% | 224B | |
+13.36% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- PTC Therapeutics, Inc. and Hopewell Campus Owner, LLC, as Successor-In-Interest to Bristol-Myers Squibb Company Enter into an Amendment and Restatement of the Lease of Office, Production and Laboratory Space At A Facility Located in Hopewell Township, New Jersey